Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis

Steinbach, William J.; Stevens, David A.
October 2003
Clinical Infectious Diseases;10/1/2003 Supplement, Vol. 37, pS157
Academic Journal
Examines the increasing incidence of invasive aspergillosis. Assessment of mortality rate; Evaluation of the reformulations of older antifungals; Exploration of immunotherapy with use of cytokines.


Related Articles

  • Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001. Steinbach, William J.; Steven, David A.; Denning, David W. // Clinical Infectious Diseases;10/1/2003 Supplement, Vol. 37, pS188 

    Examines the published in vitro studies, animal model studies and clinical reports on combination or sequential antifungal therapy of invasive aspergillosis from 1966 to 2001. Identification of synergy, additivity, indifference and antagonism; Assessment of sequential therapy; Evaluation of...

  • Caspofungin adds to aspergillosis armamentarium. Moyer, Paula // Dermatology Times;Aug2002, Vol. 23 Issue 8, p15 

    Reports the effectiveness of antifungal agent caspofungin to treat aspergillosis in the U.S. Use of the agent to immunocompromised patients; Role of itraconazole in treating aspergillosis; Percentage of the mortality rate of patients with aspergillosis.

  • CORRECTIONS.  // Annals of Internal Medicine;3/17/2015, Vol. 162 Issue 6, p463 

    A correction to the article "Combination Antifungal Therapy for Invasive Aspergillosis" that was published in a previous issue is presented.

  • An introduction to antifungal stewardship. Richardson, Malcolm D. // Journal of Antimicrobial Chemotherapy (JAC);2016 Supplement, Vol. 71, pii3 

    An introduction is presented in which the editor discusses various articles within the issue on topics including tools used to guide antifungal stewardship; treatment for fungal diseases such as aspergillosis, and candidosis; and use of diagnostics to optimize antifungal management strategies.

  • Antifungal Treatments Delineate a Correlation between Cathepsins and Cytokines in Murine Model of Invasive Aspergillosis. MITTAL, ASHWANI; GAHLAUT, ANJUM; SHARMA, G. L.; DABUR, R. // Indian Journal of Pharmaceutical Sciences;Nov/Dec2013, Vol. 75 Issue 6, p688 

    In the pathogenesis of invasive pulmonary aspergillosis both fungal and host factors play roles. Though cytokines and phagocyte, as host factors, have been shown to participate in defence against Aspergillus species yet the role of cysteine proteases, that is cathepsins, a lysosomal enzymes of...

  • Early Proinflammatory Cytokines and C-Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis. Chai, Louis Y. A.; Netea, Mihai G.; Teerenstra, Steven; Earnest, Arul; Vonk, Alieke G.; Schlamm, Haran T.; Herbrecht, Raoul; Troke, Peter F.; Kullberg, Bart-Jan // Journal of Infectious Diseases;11/1/2010, Vol. 202 Issue 9, p1454 

    Background. Monitoring treatment response in invasive aspergillosis is challenging, because an immunocompromised host may not exhibit reliable symptoms and clinical signs. Cytokines play a pivotal role in mediating host immune response to infection; therefore, the profiling of biomarkers may be...

  • Micafungin: an evidence-based review of its place in therapy. de la Torre, Pola; Reboli, Annette C. // Core Evidence;2014, Vol. 9, p27 

    Invasive fungal infections have increased throughout the world. Many of these infections occur in patients with multiple comorbidities who are receiving medications with the potential for interactions with antifungal therapy that could lead to renal and hepatic dysfunction. The second marketed...

  • Invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work. Dewhurst, A.G.; Cooper, M.J.; Khan, S.M.; Pallett, A.P.; Dathan, J.R.E. // BMJ: British Medical Journal (International Edition);10/6/90, Vol. 301 Issue 6755, p802 

    Examines the occurrence of invasive aspergillosis in immunosuppressed patients. Improvement of breathlessness following administration of diuretics; Development of cardiac failure; Use of antibiotics and antifungal agents in immunocompromised patients.

  • Report of Successful Prolonged Antifungal Therapy for Refractory Allergic Fungal Sinusitis. Andes, David; Proctor, Richard; Bush, Robert K.; Pasic, Thomas R. // Clinical Infectious Diseases;7/1/2000, Vol. 31 Issue 1, p202 

    Reports successful prolonged antifungal therapy for refractory allergic fungal sinusitis (AFS). Clinical and histopathological similarity of AFS to allergic bronchopulmonary aspergillosis; Patient's response to a prolonged course of oral itraconazole; Radiographic characterization of AFS.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics